Dozens of staff at the NIH walked out of a recent town hall meeting after Director Dr Jay Bhattacharya suggested the agency may have helped fund research that caused the COVID-19 pandemic.

Apotex has launched the first generic version of Tasigna (nilotinib), a TKI used to treat adult and pediatric patients with Ph+ CML.